A Meaningful Therapeutic For Women with Lupus

NEW YORK - June 3, 2013 - PRLog -- Approximately 1.5 million American adults have a chronic disease called lupus. More than 90% of people who have lupus are female. In the United States, lupus is more common in people of color African Americans, Hispanics/Latinos, Asian Americans, Native Americans, Native Hawaiians and Pacific Islanders than in the Caucasian population. It also appears that lupus develops at an earlier age and is more severe among members of these ethnic groups.

Lupus is a chronic disease that can affect various parts of the body, including the skin, joints, blood and kidneys. Nearly all lupus patients have mild to extreme fatigue and, approximately two-thirds of lupus patients develop skin conditions such as mouth/lip sores, and skin rash/lesions.

Currently there is no cure for lupus; the goal of treatment is to control symptoms, prevent flares and complications. The cornerstone of lupus skin disease management includes topical corticosteroids (steroids). However, ongoing topical steroid treatment contributes to adverse treatment effects such as epidermal atrophy, degeneration of the dermal structure and collagen deterioration. Ongoing topical steroid use can inhibit the skin’s ability to defend against bacterial and/or fungal infections which then makes lupus patients more vulnerable to skin conditions.

Maállois a novel post steroid skin cream. As a daily maintenance therapeutic Maállo:

1) Supports the structure & function of the skin to reduce dependency on topical steroids.

2) Facilitates healing of lupus induced rash/sores.

3) Modifies the inflammatory stimulus within the skin layers to reduce the incident and intensity of subsequent lupus dermatologic conditions.

For more information about Maállo Therapeutic Skin Cream visit:  http://www.Katha-Soma.com

● Corticosteroids drugs have anti-inflammatory effects and are used to treat conditions that involve inflammation. Corticosteroid drugs include any of several synthetic or naturally occurring substances with the general chemical structure of steroids include glucocorticoids, prednisone, prednisolone, dexamethasone, methylprednisolone, triamcinolone, and betamethasone.

Maállo Therapeutic Skin Cream is manufactured and distributed by Kathá Soma Consumer Healthcare.  Kathá Soma therapeutic formulas help people living with cancer, chronic disease or slow cell renewal due to aging, minimize their signs & symptoms, achieve daily comfort and maintain quality of life. To learn more about Kathá Soma Consumer Healthcare USA visit:  http://www.Katha-Soma.com

DISCLAIMER: Kátha Soma does not provide medical advice, diagnosis or treatment. The information provided is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.